Results 121 to 130 of about 2,003,708 (339)
ABSTRACT Blood‐based liquid biopsies hold transformative potential for non‐invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer‐associated responses, represent a compelling yet largely unexplored alternative.
Yan Ma +28 more
wiley +1 more source
Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
Background Xanthogranulomatous prostatitis is a rare, noncancerous inflammatory condition of the prostate that clinically resembles prostatic carcinoma, necessitating a pathological examination for accurate diagnosis.
Wael Abdo Hassan +3 more
doaj +1 more source
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges. [PDF]
Nava VE, Perera PY, Kumar N, Jain M.
europepmc +1 more source
Engineered extracellular vesicles displaying Ephrin‐B2 selectively target Ephrin‐B4–expressing ovarian cancer cells, enabling precise delivery in patient‐derived models. This scalable bio‐manufacturing platform reveals a versatile strategy to exploit Ephrin signaling for highly specific therapeutic payload delivery and motivates exploration of tailored
Nihar Godbole +17 more
wiley +1 more source
NEOVASCULARIZATION IN PROSTATIC ADENOCARCINOMA AS DETERMINED BY CD34: A RETROSPECTIVE STUDY
Background: Microvessel density is one of the variables that are thought to affect the natural history of prostatic carcinoma in as much as its degree influences tumor progression including the ability of invasion and metastasis.
Usama T Al-Badri +2 more
doaj +4 more sources
Single Potential Analysis of Cavernous Electric Activity in Impotent Patients: a Possible Diagnostic Method for Autonomic Cavernous Dysfunction and Cavernous Smooth Muscle Degeneration. [PDF]
Allhoff, E. P. +5 more
core +1 more source
Gene amplifications associated with the development of hormone- resistant prostate cancer [PDF]
Purpose: Hormone resistance remains a significant clinical problem in prostate cancer with few therapeutic options. Research into mechanisms of hormone resistance is essential.
Bartlett, J.M.S. +3 more
core
PD‐L1 is primarily expressed in renal tubules and upregulated in both murine models of AKI and renal biopsy samples from patients with AKI. PD‐L1 can promote adaptive TECs repair through interacting with BRCA1, independent of its canonical immunomodulatory function of T cells, and PD‐L1 supplementation may represent a promising therapeutic strategy for
Wei Jiang +17 more
wiley +1 more source
Cystic Prostatic Carcinoma - A Clinical Case and Literature Review. [PDF]
Popov SV +3 more
europepmc +1 more source

